CD80 and neoplasm: Their activation requires tumor antigens presentation by dendritic cells (DCs), co-stimulation signals (e.g., CD28-B7), and pro-inflammation cytokines [e.g., interleukin (IL)-12, interferon-gamma (IFN-γ)], leading to clonal expansion and cytotoxic effector functions acquisition (3).